CASE SERIES OF BRAF INHIBITORS FOR THE TREATMENT OF BRAFV600E GLIOBLASTOMA

被引：0
|
作者：
Wagle, Naveed [1 ,2 ]
Carrillo, Jose [3 ]
Sharma, Akanksha [1 ,2 ]
Nguyen, Minhdan [1 ,2 ]
Truong, Judy [1 ,2 ]
Chow, Jared [1 ,2 ]
Landa, Evie [3 ]
Heng, Annie [4 ]
Gill, Jaya [3 ]
Barkhoudarian, Garni [3 ]
Kelly, Daniel [3 ]
Kesari, Santosh [1 ,2 ]
机构：
[1] Providence St Johns Hlth Ctr, Pacific Neurosci Inst, Santa Monica, CA USA
[2] Providence St Johns Hlth Ctr, St Johns Canc Inst, Santa Monica, CA USA
[3] St John Canc Inst, Santa Monica, CA USA
[4] St John Canc Inst, Los Angeles, CA USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-32
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAFV600E glioblastoma results in sustained response: A case report
    Wagle, Naveed
    Sharma, Akanksha
    Nguyen, Minhdan
    Truong, Judy
    Juarez, Tiffany M.
    Kesari, Santosh
    [J]. NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [2] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    J S Wilmott
    A M Menzies
    L E Haydu
    D Capper
    M Preusser
    Y E Zhang
    J F Thompson
    R F Kefford
    A von Deimling
    R A Scolyer
    G V Long
    [J]. British Journal of Cancer, 2013, 108 : 924 - 931
  • [3] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    Wilmott, J. S.
    Menzies, A. M.
    Haydu, L. E.
    Capper, D.
    Preusser, M.
    Zhang, Y. E.
    Thompson, J. F.
    Kefford, R. F.
    von Deimling, A.
    Scolyer, R. A.
    Long, G. V.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 924 - 931
  • [4] Resistance to BRAF and MEK inhibitors in BRAFV600E mutant melanoma
    Patel, Hima
    Mishra, Rosalin
    Joan, Garrett
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] Mutant specific mitochondrial localization of BRAFV600E: Clinically used BRAF kinase inhibitors are not able to block mitochondrial actions of BRAFV600E
    Lee, Min Hee
    Kim, Koon Soon
    Lee, Seong Eun
    Ryu, Min Jeong
    Kim, Soung Joong
    Kim, Yong Kyoung
    Kweon, Gi Ryang
    Jo, Young Suk
    Shong, Minho
    [J]. CANCER RESEARCH, 2010, 70
  • [6] Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature
    Li, Yan
    Yang, Shoubo
    Hao, Chengcheng
    Chen, Janxin
    Li, Shan
    Kang, Zhuang
    Kang, Xun
    Zhang, Hongmei
    Li, Wenbin
    [J]. CLINICAL LABORATORY, 2020, 66 (08) : 1629 - 1633
  • [7] Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAFV600E melanoma
    Hu-Lieskovan, Siwen
    Mok, Stephen
    Moreno, Blanca Homet
    Tsoi, Jennifer
    Robert, Lidia
    Goedert, Lucas
    Pinheiro, Elaine M.
    Koya, Richard C.
    Graeber, Thomas G.
    Comin-Anduix, Begona
    Ribas, Antoni
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (279)
  • [8] Molecular Pathways: Response and Resistance to BRAF and MEK Inhibitors in BRAFV600E Tumors
    Das Thakur, Meghna
    Stuart, Darrin D.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (05) : 1074 - 1080
  • [9] BRAFV600E and BRAF-inactivating mutations in NSCLC
    Rosell, Rafael
    Karachaliou, Niki
    [J]. LANCET ONCOLOGY, 2017, 18 (10): : 1286 - 1287
  • [10] Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report
    Janik, Karolina
    Och, Waldemar
    Popeda, Marta
    Rosiak, Kamila
    Peciak, Joanna
    Rieske, Piotr
    Kulbacki, Kamil
    Szostak, Blazej
    Parda, Agnieszka
    Stoczynska-Fidelus, Ewelina
    [J]. FOLIA NEUROPATHOLOGICA, 2019, 57 (01) : 72 - 79
12345